Abstract
Atopic dermatitis (AD) is a common inflammatory skin disease with a global prevalence ranging from 3% to 20%. Patients with AD have an increased risk for complications after viral infection (eg, herpes simplex virus), and vaccination of patients with AD with live vaccinia virus is contraindicated because of a heightened risk of eczema vaccinatum, a rare but potentially lethal complication associated with smallpox vaccination. We sought to develop a better understanding of immunity to cutaneous viral infection in patients with AD. In a double-blind randomized study we investigated the safety and immunogenicity of live attenuated yellow fever virus (YFV) vaccination of nonatopic subjects and patients with AD after standard subcutaneous inoculation or transcutaneous vaccination administered with a bifurcated needle. Viremia, neutralizing antibody, and antiviral T-cell responses were analyzed for up to 30 days after vaccination. YFV vaccination administered through either route was well tolerated. Subcutaneous vaccination resulted in higher seroconversion rates than transcutaneous vaccination but elicited similar antiviral antibody levels and T-cell responses in both the nonatopic and AD groups. After transcutaneous vaccination, bo...Continue Reading
References
Dec 13, 1985·JAMA : the Journal of the American Medical Association·R R RedfieldW H Bancroft
Apr 20, 1970·JAMA : the Journal of the American Medical Association·J M LaneJ D Millar
Sep 24, 1998·Journal of Medical Virology·B ReinhardtJ L'age-Stehr
Jun 26, 2003·JAMA : the Journal of the American Medical Association·John D Grabenstein, William Winkenwerder
Aug 20, 2003·Nature Medicine·Erika HammarlundMark K Slifka
Sep 1, 1960·Transactions of the Royal Society of Tropical Medicine and Hygiene·P D MEERS
Mar 5, 2004·Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology·Nora Laske, Bodo Niggemann
Nov 5, 2004·The New England Journal of Medicine·Robert B BelsheGary Dubin
Nov 5, 2004·The New England Journal of Medicine·Richard T KenneyGregory M Glenn
Mar 21, 2007·Vaccine·Alan D T BarrettDirk E Teuwen
Apr 4, 2008·The New England Journal of Medicine·Thomas Bieber
Apr 10, 2008·Human Vaccines·Ian J AmannaMark K Slifka
Apr 24, 2008·PloS One·Anna H RoukensLeo G Visser
May 13, 2008·Immunity·Joseph D MillerRafi Ahmed
Sep 24, 2008·Vaccine·Nicole P LindseyEdward B Hayes
Jun 23, 2009·The Journal of Allergy and Clinical Immunology·Lisa A BeckDonald Y M Leung
Mar 8, 2011·Bulletin of the World Health Organization·J K HicklingD Kristensen
Apr 8, 2011·The New England Journal of Medicine·Thomas P MonathDennis W Trent
Feb 1, 2012·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jennifer L ReedMike Bray
Apr 6, 2012·Expert Opinion on Drug Delivery·Sharifa Al-ZahraniRyan F Donnelly
Jul 27, 2012·Therapeutic Delivery·Ronald J Pettis, Alfred J Harvey
Sep 15, 2012·Influenza and Other Respiratory Viruses·Fawziah MarraCarlo A Marra
Citations
Jan 16, 2016·Nanomedicine : Nanotechnology, Biology, and Medicine·Monika KauravRavi Shankar Pandey
Jan 8, 2016·The Journal of Allergy and Clinical Immunology·Hyo Jin KwonYoung J Juhn
Feb 5, 2015·The Journal of Allergy and Clinical Immunology·Michiko K OyoshiRaif S Geha
Apr 7, 2015·The Journal of Allergy and Clinical Immunology·Michelle A Barron, Donald Y M Leung
Feb 11, 2015·The Journal of Allergy and Clinical Immunology·Scott H Sicherer, Donald Y M Leung
Jan 15, 2015·The Journal of Allergy and Clinical Immunology·Joel Correa da RosaEmma Guttman-Yassky
Aug 11, 2016·HLA : Immune Response Genetics·Y H SheenY J Juhn
Jan 15, 2017·The Journal of Allergy and Clinical Immunology·Regina K RoweMichelle A Gill
Jul 28, 2017·Clinical & Translational Immunology·Lázaro GilLisset Hermida
May 10, 2020·Viruses·Robert Andreata-SantosLuís Carlos de Souza Ferreira
Jan 14, 2020·Xenotransplantation·Helen L WuJonah B Sacha
Apr 25, 2017·Clinical & Translational Immunology·Laura Lazo VázquezLisset Hermida Cruz
Feb 25, 2017·Current Allergy and Asthma Reports·Regina K Rowe, Michelle A Gill
Jun 26, 2021·Human Vaccines & Immunotherapeutics·Oriana SimonettiAnnamaria Offidani